Claritev Corp. (CTEV)
23.72
+2.41
(+11.31%)
USD |
NYSE |
Oct 02, 16:00
23.36
-0.36
(-1.52%)
After-Hours: 20:00
Claritev Cash from Operations (TTM) : 133.04M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 133.04M |
| March 31, 2026 | 105.87M |
| December 31, 2025 | 117.32M |
| September 30, 2025 | 17.01M |
| June 30, 2025 | 70.00M |
| March 31, 2025 | 22.96M |
| December 31, 2024 | 107.00M |
| September 30, 2024 | 168.73M |
| June 30, 2024 | 168.01M |
| March 31, 2024 | 157.22M |
| December 31, 2023 | 171.72M |
| September 30, 2023 | 171.71M |
| Date | Value |
|---|---|
| June 30, 2023 | 208.62M |
| March 31, 2023 | 241.64M |
| December 31, 2022 | 372.36M |
| September 30, 2022 | 377.94M |
| June 30, 2022 | 435.94M |
| March 31, 2022 | 428.72M |
| December 31, 2021 | 404.69M |
| September 30, 2021 | 416.50M |
| June 30, 2021 | 389.90M |
| March 31, 2021 | 400.89M |
| December 31, 2020 | 377.37M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| LataMed AI Corp. | -0.2553M |
| SCWorx Corp. | -0.7456M |
| Health Catalyst, Inc. | 28.23M |
| GoodRx Holdings, Inc. | 201.58M |
| iSpecimen, Inc. | -7.004M |